Director, Financial Planning & Analysis; Biotech

Director, Financial Planning & Analysis (FP&A)

Salary Band: $190,000-$240,000

Location: Boston, MA or New York, NY

Antares Therapeutics is seeking an experienced Director of Financial Planning & Analysis (FP&A) to serve as a strategic finance partner to R&D and corporate leadership. This role will report directly to the VP of Finance and will operate as a hands‑on, highly autonomous individual contributor with significant visibility and influence across the organization.

The ideal candidate brings a blend of strategy, management consulting, or finance advisory experience and embedded industry experience within a biotech organization, with a strong understanding of biotech financial models and R&D investment decision-making. This person will act as the primary FP&A lead for the company, capable of independently partnering with functional leaders across departments on detailed actuals, forecasting, and planning.

Prior experience supporting oncology and/or immunology programs and partnering closely with Research & Development leadership is a significant plus.

• Serve as a strategic finance partner to functional leadership, providing financial insights to support investment decisions, portfolio prioritization, and long‑range planning
• Lead all aspects of budgeting, forecasting, and long‑range financial planning, with a strong focus on R&D spend
• Develop and maintain detailed financial models related to pipeline programs, development plans, and clinical milestones
• Partner closely with Research, Development, Clinical, and Technical Operations leaders to align financial plans with scientific and operational objectives
• Support scenario modeling and sensitivity analyses to inform strategic initiatives and corporate planning
• Prepare board‑ and executive‑level materials, including financial analyses, variance explanations, and strategic recommendations
• Own and continuously enhance FP&A processes, tools, and reporting, with a strong emphasis on scalability and accuracy
• Serve as a subject matter expert for Workday Adaptive Planning, driving adoption, optimization, and effective use across the organization
• Support ad‑hoc financial analyses related to partnering, business development, and corporate strategy as needed

• Bachelor’s degree in Finance, Accounting, Economics, or a related field; MBA or CPA strongly preferred
• 8+ years of progressive FP&A experience, including hands‑on ownership of planning, forecasting, and financial modeling
• Prior experience in strategy, management consulting, or finance advisory roles, paired with experience fully embedded within a biotech or life sciences company
• Strong understanding of biotech financial drivers, particularly R&D and clinical development spending
• Oncology experience and prior partnership with R&D leadership is a major plus
• Hands‑on experience with Workday Adaptive Planning (required)
• Advanced financial modeling, forecasting, and data analysis skills
• Proven ability to independently engage with functional leaders and translate complex financial data into clear, actionable insights; highly collaborative, proactive, and comfortable operating with minimal supervision in a fast‑paced, evolving environment
• Ability to operate successfully as an individual contributor without direct reports

The anticipated annual salary range for this position is $190,000-$240,000 annually.

As set forth in Antares Therapeutics ’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.